#India #Clinical Trials #Ahmedabad #Veeda Lifesciences #Mango Sciences

Veeda Lifesciences and Mango Sciences Unite for AI Innovation in Clinical Trials

Ahmedabad, India — In a groundbreaking move that promises to revolutionize the clinical trials landscape, Veeda Lifesciences has announced a strategic partnership with Boston-based Mango Sciences, well-known for its advanced healthcare AI solutions. This collaboration signifies a pivotal investment aimed at harnessing artificial intelligence to enhance the efficacy, speed, and quality of clinical trials conducted by Veeda across its extensive global network.

The integration of Mango Sciences' AI-powered Querent™ platform will enable Veeda to automate patient identification processes with greater precision. The use of AI technology is set to broaden Veeda's recruitment capabilities, ensuring a more diverse and representative patient selection process worldwide. This is increasingly critical in today’s regulatory environment where diversity in clinical trials is paramount to meet the expectations of both regulators and pharmaceutical companies.

Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Clinical Research Limited, expressed his enthusiasm about the partnership, stating, “Our partnership will transform Veeda into an AI-driven oncology drug development organization, meeting the growing demand for diversity in clinical trials.” He highlighted that this strategic alliance places Veeda among a select group of CROs focusing on oncology and equipped with proprietary technology that can significantly streamline processes.

Veeda’s objectives go beyond just operational efficiency; the partnership also reflects the company's commitment to technological modernization and digital transformation in clinical research. With the deployment of Querent™, Veeda anticipates improvements not only in data management capabilities but also in overall quality assurance standards. Importantly, this innovation aims for better representation of non-Caucasian populations, thus enhancing the generalizability of clinical research outcomes.

Furthermore, advanced data analytics will optimize patient matching, trial design, and monitoring processes, which in turn should lead to reduced costs and shorter trial timelines. Dr. Mohit Misra, Founder and CEO of Mango Sciences, echoed this sentiment, stating, “We are integrating Large Language Models (LLMs) and Generative-AI into Querent™ to drive operational efficiencies and improve real-world evidence.” The goal is to ensure that the right drug reaches the right patient efficiently.

This collaboration marks a significant step for Veeda, positioning the company as a tech-driven CRO through its investment strategies, including its previous acquisition of Health Data Specialists (Heads). This move enhances Veeda's access to oncology patient cohorts in India and Europe, thereby providing exclusive access to a wider pool of eligible patients.

As the regulatory landscape evolves, the demand for CROs that can adapt and innovate is accelerating. Veeda’s partnership with Mango Sciences is a proactive approach to stay at the forefront of the CRO sector, delivering specialized services to pharmaceutical and biopharmaceutical clients worldwide.

About Veeda Lifesciences

Veeda Lifesciences, also known as Veeda Clinical Research Limited, offers a comprehensive suite of services throughout the drug development lifecycle. Their focus is on supporting small to medium-sized biotech and pharmaceutical firms through various phases, from non-clinical and pre-clinical development to clinical pharmacology and trials across diversified modalities.

About Mango Sciences

Mango Sciences is an innovative healthcare data and AI technology enterprise dedicated to transforming patient care through cutting-edge data analytics and solutions. Founded by a team of industry veterans, Mango Sciences aims to enhance patient representation and expand access to comprehensive healthcare.

For further details on Veeda Lifesciences, visit veedalifesciences.com and for Mango Sciences, visit mangosciences.com.